Dataset Information
Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib.
Ontology highlight
ABSTRACT:
SUBMITTER: King B
PROVIDER: S-EPMC5387413 | biostudies-literature | 2017 Apr
REPOSITORIES: biostudies-literature